Trends in Pharmacological Sciences
OpinionInsights into drug discovery from natural medicines using reverse pharmacokinetics
Section snippets
Drug discovery from NMs: promises and challenges
The development of molecular and structural biology, combinatorial chemistry, and high-throughput screening (HTS) has created a rapid process for designing and discovering drug candidates with high selectivity and high affinity to a defined molecular target. This has been a mainstream drug discovery paradigm since the 1990s and was initially heralded to promise a large drug discovery pipeline at decreased cost. In sharp contrast to this originally conceived picture, the pharmaceutical industry
Why ‘reverse pharmacokinetics’?
Target-based drug discovery is a process that moves from ‘laboratory to clinic’, whereas the reverse pharmacology-guided drug discovery of NMs features a reverse process of ‘clinic to laboratory’. Although such a difference is very clear, it seems that this discrepancy has not received sufficient consideration in drug development, where the same paradigm, strategy, theory, and methodology have been employed for target-based and reverse pharmacology-guided drug discovery. Pharmacokinetic
How might ‘reverse pharmacokinetics’ help development of NMs?
The purpose of ‘reverse pharmacokinetics’ is not to define whether the DMPK properties are appropriate but rather to determine the mechanistic links between the DMPK properties (e.g., absorption, distribution profile/kinetics, metabolism, pharmacokinetic profile, and the interaction with drug metabolizing enzymes/transporters, etc.) and in vivo pharmacological efficacies. For NMs with validated therapeutic benefits, knowledge obtained from the ‘reverse pharmacokinetics’ can be used for cluing
Methodological innovation in reverse pharmacokinetics of NMs
The DMPK study of natural compounds is a key process in reverse pharmacokinetics of NMs but represents an extremely challenging task. The complex and largely unknown chemical compositions, diverse physiochemical properties, low concentrations, extensive and elusive metabolism, biological matrix interference, and the lack of standard compounds superimpose the complexity on the DMPK study of NMs [81]. Fortunately, a panel of innovative strategies has recently been developed to address these
Concluding remarks
In contrast to the target-based design of drugs, reverse pharmacology-guided discovery of NMs starts from the phenotype screening of natural compounds for which the molecular targets and mechanisms are largely elusive. In spite of this huge difference, it seems that the same decision paradigms throughout the whole drug discovery pipeline have been applied to both types of drug discovery. This has led to a great dilemma in that many natural compounds are characterized with pleiotropic
Acknowledgments
Work in our laboratory was supported in part by the National Natural Science Foundation of China (numbers 81325025, 91029746, and 81273586); the Natural Science Foundation of Jiangsu province (BK2012026); and the Jiangsu Province Key Laboratory of Drug Metabolism and Pharmacokinetics Projects (BM2012012).
References (86)
Natural products in drug discovery
Drug Discov. Today
(2008)- et al.
Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?
Drug Discov. Today
(2009) Angiogenesis: from plants to blood vessels
Trends Pharmacol. Sci.
(2006)Where is the hope for drug discovery? Let history tell the future
Drug Discov. Today
(2009)- et al.
Molecular understanding and modern application of traditional medicines: triumphs and trials
Cell
(2007) - et al.
Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets
Trends Pharmacol. Sci.
(2009) Target-based selection of flavonoids for neurodegenerative disorders
Trends Pharmacol. Sci.
(2012)- et al.
The pharmacology of curcumin: is it the degradation products?
Trends Mol. Med.
(2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases
Cell
(2012)- et al.
Curcumin in clinical practice: myth or reality?
Trends Pharmacol. Sci.
(2009)
Curcumin as ‘Curecumin’: from kitchen to clinic
Biochem. Pharmacol.
Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice
Gastroenterology
Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial
Clin. Gastroenterol. Hepatol.
Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk
Cell Metab.
Ginseng pharmacology: multiple constituents and multiple actions
Biochem. Pharmacol.
Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cells
Blood
Towards a ‘systems’-level understanding of the nervous system and its disorders
Trends Neurosci.
Cancer cachexia: malignant inflammation, tumorkines, and metabolic mayhem
Trends Endocrinol. Metab.
Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia
Neuroscience
Ginsenoside Rg1 protection against β-amyloid peptide-induced neuronal apoptosis via estrogen receptor α and glucocorticoid receptor-dependent anti-protein nitration pathway
Neuropharmacology
Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration
Cell
Treating the periphery to ameliorate neurodegenerative diseases
Cell
Taking advantage of the systemic immune system to cure brain diseases
Neuron
Inflammatory pathways of seizure disorders
Trends Neurosci.
Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula
Syst. Appl. Microbiol.
Where do health benefits of flavonoids come from? Insights from flavonoid targets and their evolutionary history
Biochem. Biophys. Res. Commun.
Pathways in microbe-induced obesity
Cell Metab.
Pharmacological tools for the development of traditional Chinese medicine
Trends Pharmacol. Sci.
Compatibility art of traditional Chinese medicine: from the perspective of herb pairs
J. Ethnopharmacol.
Pharmacokinetic comparisons of schizandrin after oral administration of schizandrin monomer, Fructus Schisandrae aqueous extract and Sheng-Mai-San to rats
J. Ethnopharmacol.
An integral strategy toward the rapid identification of analogous nontarget compounds from complex mixtures
J. Chromatogr. A
A decade of fragment-based drug design: strategic advances and lessons learned
Nat. Rev. Drug Discov.
Drug discovery and natural products: end of an era or an endless frontier?
Science
Natural products as leads to potential drugs: an old process or the new hope for drug discovery?
J. Med. Chem.
The evolving role of natural products in drug discovery
Nat. Rev. Drug Discov.
Revisiting the ancient concept of botanical therapeutics
Nat. Chem. Biol.
Curcumin structure–function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease
J. Pharmacol. Exp. Ther.
The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats
J. Clin. Invest.
Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug-delivery, and membrane interactions
Curr. Med. Chem.
21st century natural product research and drug development and traditional medicines
Nat. Prod. Rep.
Pharmacokinetics–pharmacology disconnection of herbal medicines and its potential solutions with cellular pharmacokinetic–pharmacodynamic strategy
Curr. Drug Metab.
Bioavailability of curcumin: problems and promises
Mol. Pharm.
Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG
Clin. Cancer Res.
Cited by (78)
Physical fingerprint transformation of herbal medicines powders using near-infrared spectroscopy
2023, Advanced Powder TechnologyCurcumin in human osteosarcoma: From analogs to carriers
2023, Drug Discovery TodayPharmacokinetics
2023, Pharmacognosy: Fundamentals, Applications, and Strategies, Second EditionEmerging targetome and signalome landscape of gut microbial metabolites
2022, Cell MetabolismPhospholipid complexation: A versatile technique for delivery of phytomedicine
2022, Evidence-Based Validation of Herbal Medicine: Translational Research on Botanicals
- *
These authors contributed equally to this work.